Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin prophylaxis in populations exposed to COVID-19 patients
IRCT20200408046987N3Phase 3Completed
- Sponsor
- Akam Tejarat Fartak Farasoo
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Akam Tejarat Fartak Farasoo. Started Nov 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200408046987N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046987N3.